Status:
RECRUITING
WiserAD: The Effect of a Structured Online Intervention on Antidepressant Deprescribing in Primary Care
Lead Sponsor:
University of Melbourne
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Conditions:
Depression
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The use of antidepressants (ADs) is increasing globally, including within Australia, which has one of the highest rates of AD prescribing. Despite clear benefits for many people, there is reason to be...
Detailed Description
Antidepressants (ADs) have significantly improved the health and wellbeing for very many people and their success in enabling those with depression to retain their quality of life has undoubtedly led ...
Eligibility Criteria
Inclusion
- 18-75 years
- Stable on AD for \>=12m (no depressive episodes)
- No history of recurrent depression
- Sufficient English language proficiency to provide informed consent
- No or mild depressive symptoms (PHQ-9)
- Low risk of Suicide or Self-harm
- Agree to consider reviewing their AD use
- Agree to be randomized into the study
- Willing to provide informed consent
Exclusion
- Moderate/severe depressive symptoms (PHQ-9 ≥10) at study entry or history of severe or recurrent depression
- Experienced a major life event in the past 3 months, or foresee one occurring in the next 3 months (e.g. trauma, grief, loss of role, major health issue, financial crisis)
- Continued AD use indicated for other condition (e.g. anxiety)
- Currently prescribed a non-SSRI/SNRI AD, antipsychotic, or mood stabiliser
- No internet access.
Key Trial Info
Start Date :
May 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 7 2025
Estimated Enrollment :
312 Patients enrolled
Trial Details
Trial ID
NCT05355025
Start Date
May 25 2022
End Date
August 7 2025
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Social Media
Melbourne, Australia